Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators..

Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.

2.

Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.

Carlsson S, Berglund A, Sjoberg D, Khatami A, Stranne J, Bergdahl S, Lodding P, Aus G, Vickers A, Hugosson J.

BMC Urol. 2014 Mar 6;14:25. doi: 10.1186/1471-2490-14-25.

3.

Hyperbaric oxygen treatment in radiation-induced cystitis and proctitis: a prospective cohort study on patient-perceived quality of recovery.

Oscarsson N, Arnell P, Lodding P, Ricksten SE, Seeman-Lodding H.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):670-5. doi: 10.1016/j.ijrobp.2013.07.039. Epub 2013 Sep 11.

PMID:
24035333
4.

Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.

Ragnarsson O, Johannsson G, Geterud K, Lodding P, Dahlqvist P.

BMJ Case Rep. 2013 Aug 13;2013. pii: bcr2013010395. doi: 10.1136/bcr-2013-010395.

5.

Prostate-cancer mortality at 11 years of follow-up.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators..

N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135. Erratum in: N Engl J Med. 2012 May 31;366(22):2137.

6.

Inguinal hernia after radical retropubic prostatectomy: risk factors and prevention.

Stranne J, Lodding P.

Nat Rev Urol. 2011 May;8(5):267-73. doi: 10.1038/nrurol.2011.40. Epub 2011 Apr 5. Review.

PMID:
21467967
7.

The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial.

Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Stranne J, Hugosson J.

Eur J Cancer. 2011 Mar;47(4):545-53. doi: 10.1016/j.ejca.2010.10.016. Epub 2010 Nov 17.

PMID:
21087857
8.

Post-radical prostatectomy inguinal hernia: a simple surgical intervention can substantially reduce the incidence--results from a prospective randomized trial.

Stranne J, Aus G, Bergdahl S, Damber JE, Hugosson J, Khatami A, Lodding P.

J Urol. 2010 Sep;184(3):984-9. doi: 10.1016/j.juro.2010.04.067.

PMID:
20643442
9.

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H.

Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.

10.

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators..

N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.

11.

Inguinal hernia is a common complication in lower midline incision surgery.

Stranne J, Hugosson J, Lodding P.

Hernia. 2007 Jun;11(3):247-52. Epub 2007 Apr 4.

PMID:
17406787
12.

Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years.

Iversen P, Johansson JE, Lodding P, Kylmälä T, Lundmo P, Klarskov P, Tammela TL, Tasdemir I, Morris T, Armstrong J; Scandinavian Prostate Cancer Group..

Scand J Urol Nephrol. 2006;40(6):441-52.

PMID:
17130095
14.

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section.

Khatami A, Aus G, Damber JE, Lilja H, Lodding P, Hugosson J.

Int J Cancer. 2007 Jan 1;120(1):170-4. Erratum in: Int J Cancer. 2007 Sep 15;121(6):1399. Ali, Khatami [corrected to Khatami, Ali]; Gunnar, Aus [corrected to Aus, Gunnar]; Jan-Erik, Damber [corrected to Damber, Jan-Erik]; Hans, Lilja [corrected to Lilja, Hans]; Pär, Lodding [corrected to Lodding, Pär]; Jonas, Hugosson [corrected to Hugosson, Jonas].

15.
17.
18.

Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.

Iversen P, Johansson JE, Lodding P, Lukkarinen O, Lundmo P, Klarskov P, Tammela TL, Tasdemir I, Morris T, Carroll K; Scandinavian Prostatic Cancer Group..

J Urol. 2004 Nov;172(5 Pt 1):1871-6.

PMID:
15540741
19.

Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.

Tyrrell CJ, Payne H, Tammela TL, Bakke A, Lodding P, Goedhals L, Van Erps P, Boon T, Van De Beek C, Andersson SO, Morris T, Carroll K.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):476-83.

PMID:
15380582
20.

Single-dose orally administered quinolone appears to be sufficient antibiotic prophylaxis for radical retropubic prostatectomy.

Stranne J, Aus G, Hansson C, Lodding P, Pileblad E, Hugosson J.

Scand J Urol Nephrol. 2004;38(2):143-7.

PMID:
15204401

Supplemental Content

Loading ...
Support Center